Feasibility and Acceptability of Powdered Multinutrient Formula
1 other identifier
interventional
20
1 country
1
Brief Summary
The study aims to test the feasibility and acceptability of 1) consumption of EMPowerplus Lightning Sticks, 2) at-home collection of blood and urine samples, and 3) remote visits and completion of online behavioral questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 19, 2022
CompletedFirst Posted
Study publicly available on registry
February 10, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedApril 4, 2025
April 1, 2025
6 months
January 19, 2022
April 1, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Feasibility measured by count of remaining Sticks
Feasibility will be determined if consumption of one Lightning Stick daily is achieved when greater than or equal to 80% of provided Sticks were taken. Measured by count of remaining (unused) Sticks.
week 6
Abbreviated Acceptability Rating Profile - 7 questions on a 6-point Likert scale
Acceptability of taking the Lightning Sticks will be measure through 7 questions with a 6-point Likert-scale, (range: Strongly Disagree to Strongly Agree) Acceptability will be achieved if greater than or equal to 70% of children and parents report that taking powdered multinutrients is acceptable, at or above the Agree range.
week 6
Secondary Outcomes (7)
Feasibility measured by count of participants who provide blood using the Tasso device
once, at baseline
Acceptability measured by a 'yes' response to their preference of using the Tasso device instead of a lab-based blood draw
once, at baseline
Feasibility measured by count of participants who provide the dried urine sample
once, at baseline
Acceptability measured by a 'yes' response to their preference of using the at-home dried urine sample collection method instead of a lab-based urine sample collection method
once, at baseline
Feasibility of remote study visits measured by count of participants who complete all online remote study visits
week 6
- +2 more secondary outcomes
Study Arms (1)
Lightning Stick
OTHERFeasibility and acceptability
Interventions
multinutrient supplement containing vitamins, minerals, amino acids and antioxidants taken one Stick daily by dissolving the powder on or under the tongue
Eligibility Criteria
You may qualify if:
- Age inclusive of and between 7 and 16 years at the time of enrollment
- Verbally willing to ingest one EmpowerPlus Lightning Stick daily
- Attend all virtual study appointments and complete questionnaires
- Have been previously enrolled in a multinutrient study OR complete a screening to match with participants from that study in terms of age and symptoms of ADHD and emotional dysregulation
- Be medication and supplementation free (if supplement ingredient is contained in the Lightning Stick) prior to study initiation
- Willing to collect blood and urine samples, once, at home.
You may not qualify if:
- Neurological disorder involving brain or other central function (e.g., history of, or suspected, intellectual disability, autism spectrum disorder, epilepsy, multiple sclerosis, narcolepsy) or other major psychiatric condition requiring hospitalization (e.g. significant mood disorder, active suicidal ideation, or psychosis), based on parent/guardian self-report of child's condition
- Any serious medical condition, including inflammatory bowel disease, history of cancer, kidney or liver disease, hyperthyroidism, diabetes Type I or II
- Known allergy to any ingredients of the intervention
- Any known abnormality of mineral metabolism (e.g., Wilson's disease, hemochromatosis)
- Taking any medication with primarily central nervous system activity, including stimulants used to treat symptoms of ADHD
- Any disability that would interfere with participant answering questions verbally
- Non-English speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oregon Health & Science University
Portland, Oregon, 97239, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeanette Johnstone, PhD
Oregon Health and Science University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 19, 2022
First Posted
February 10, 2022
Study Start
August 1, 2022
Primary Completion
February 2, 2023
Study Completion
April 30, 2023
Last Updated
April 4, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share